HIGHLIGHTED ARTICLES FROM ANNALS OF SURGICAL ONCOLOGY
The Landmark Series: Minimally Invasive Pancreatic Resection
Ann Surg Oncol (2020).
van Hilst, J., de Graaf, N., Abu Hilal, M. et al.
Citation: van Hilst, J., de Graaf, N., Abu Hilal, M. et al. The Landmark Series: Minimally Invasive Pancreatic Resection. Ann Surg Oncol (2020).
Synopsis: This study reviews and summarizes the available randomized controlled trials evaluating the role of minimally invasive approaches (both robot-assisted and laparoscopic) for pancreatic resections.
Ann Surg Oncol 25, 3572–3579 (2018).
Rouanet, P., Bertrand, M.M., Jarlier, M. et al.
Citation: Rouanet, P., Bertrand, M.M., Jarlier, M. et al. Robotic Versus Laparoscopic Total Mesorectal Excision for Sphincter-Saving Surgery: Results of a Single-Center Series of 400 Consecutive Patients and Perspectives. Ann Surg Oncol 25, 3572–3579 (2018).
Synopsis: This monocentric series of 400 consecutive rectal resections, 200 laparoscopic, 200 robotic, reports a significant lower conversion rate to open laparotomy and transanal TME with robotic surgery. It emphasizes the power of robotics for difficult resections in a deep pelvis.
Listen to the ASO's new podcast, Speaking of SurgOnc
Speaking of SurgOncis a podcast brought to you by theAnnals of Surgical Oncology (ASO) and the Society of Surgical Oncology (SSO).
The series is hosted by ASO Deputy Editor Dr. Frederick L. (Rick) Greene, who will expand upon ideas from articles published in theAnnals. Once a month, Dr. Greene will interview authors and leading experts in surgical oncology.
Listen to the podcasthere.
ASO – The Leading Resource in Surgical Oncology
Annals of Surgical Oncology (ASO) hails 2019 as a year of growth and influence with a 13% increase in editorials, the addition of a two new editorial sections and the introduction of “ASO Author Reflections.” ASO also had more than 1 million article downloads, a demonstration of the quality and relevance of the research published. Read more about ASO.
ASO is the journal of choice of surgical oncologists and cancer multidisciplinary teams worldwide regarding surgical oncology research and education, and benefits surgeons, oncologists, hematologists, radiologists, general practitioners, pathologists, researchers, academicians, and other clinical professionals interested in all aspects of the surgical treatment of cancer. ASO strives to improve the practice environment in which high-quality surgical oncology care is delivered, to enhance the quality of life and survival of the surgical patient with cancer.